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restricted differentiation potential were the
source of the individual differentiated
lineages that arose. Indeed, injection of
spheres into nude mice did not form tera-
tomas, which are typically observed after
the transfer of ESCsor iPSCs. TheSP frac-
tion isolated from the spheres was highly
tumorigenic, but if this subpopulation
indeed comprised ESC-like cells, why did
the tumors only show neuronal differentia-
tion and not cartilage, muscle, bone,
etc., as seen in ESC-derived teratomas?
Furthermore, attempts to isolate iPSC lines
fromsphereshave failed thus far.Basedon
these deficiencies, the authors do not
claim that the spheres contain iPSCs. It is
possible, rather, that the ESC-like cells
arising in spheres may not have achieved
the full autonomy of truly pluripotent
ESCs, and instead remain dependent
on a specific microenvironment. Intimate
cell-cell contacts that are present within
the sphere structures and are lost upon
culturing under adherent conditions may
provide essential maintenance cues.
Thus, the suspension culture of MEFs
may induce niches that are required to
both induce and maintain the reprogram-
ming of the subset of cells that adopt
characteristics of iPSCs and cancer stem
cells.
The findings of Liu et al. are important
because they add to the ongoing discus-
sion of the origin and significance of
stem cells in tumor development (dis-
cussed in Jordan, 2009). One current
view suggests that cancer arises from
(epi)genetic transformation of normal
stem cells into cancer stem cells that
support tumor growth, sustain metas-
tasis, and are responsible for treatment
failure. An alternative view is that tumor
cells can originate fromdifferentiated cells
and that the developing tumor creates
niches where differentiated tumor cells
become reprogrammed to adopt stem
cell characteristics. This second concept
is mirrored in the plant kingdom, where
the sprouting of roots and shoots relies
on the creation of novel stem cell
niches in a context of differentiated cells
(Scheres, 2007). The current work of Liu
et al. suggests that a similar mechanism
may operate during tumor development
in animals. Finally, should it be possible
to culture iPSC lines from the spheres
described by the authors, this method
may lead to safer protocols for derivation
of iPSCs to be exploited in regenerative
medicine and gene therapy of inherited
disease.
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WNT and PGE2 signaling pathways are each associated with stem cell activity in the hematopoietic system. In
a recent issueofCell,Goesslingetal. (2009)use thezebrafishmodel to reveal aconservedPKA-dependentmech-
anism that connects the two pathways via b-catenin, enhancing stem cell proliferation and tissue regeneration.Novel insight intocancerbiologyhascome
from advances in the stem cell field, with
the concept of a cancer stem cell suggest-
ing candidate pathways used to target
small populations of tumor cells resistant
to standard therapies. But the analogy
can work both ways, and signaling mech-
anisms that modulate tumor cell pheno-
types might also be applied to regenera-280 Cell Stem Cell 4, April 3, 2009 ª2009 Etive medicine. This insight is one of two
lessons learned from a study investigating
how prostaglandins (PGE2) modulate the
WNT signaling pathway (Goessling et al.,
2009), published recently in Cell.
Familial adenomatous polyposis (FAP)
is a condition characterized by hundreds
of benign colonic polyps, some of which
eventually progress to colon cancer. FAPlsevier Inc.is caused by mutations of the APC gene,
a tumor suppressor that along with Axin,
GSK3b, and CK1 comprise the ‘‘destruc-
tion complex,’’ which limits the accumula-
tion of stable, typically proproliferative
b-catenin. In an early case report, Waddell
and Loughry (1983) observed that polyps
were largely eradicated in several FAP
patients given sulindac, an NSAID shown
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PreviewsFigure 1. The Same, but Different
In colon carcinoma cell lines (left) and HSCs (right), WNT signaling activates b-catenin through a common
canonical pathway, whereby frizzled receptor (FRZ) activation inhibits the destruction-complex-depen-
dent turnover of b-catenin. However, PGE2 signaling through EP GPCRs may cooperate with WNT via
different mechanisms. In a cancer cell, signaling has been shown to affect Axin, PI3K, and PKA activities
to indirectly synergize with WNT, while the data from Goessling et al. support a more direct role for PKA
targeting of b-catenin. Note that in cancer cell lines, APC is mutant, and this alteration might account for at
least some of the observed differences. In both cases, the net result is that effective WNT signaling is
dependent on cosignaling from PGE2 for expression of target genes including Cox2, cMyc, and Cyclin
D1, promoting cell survival and proliferation.in previous animal studies to inhibit chem-
ically induced polyps. NSAIDs are known
to inhibit cyclooxygenase (COX) enzymes
and thereby limit the synthesis of PGE2.
Ten years later, the efficacy of sulindac
for significantly repressing colorectal
adenoma in FAP was confirmed by
a controlled clinical trial (Giardiello et al.,
1993). Cancer researchers have since
tried to establish the mechanistic link
between APC and NSAIDs by focusing
on the two major signaling pathways that
are implicated: WNTs and PGE2. Do they
converge and, if so, how?
Cellular levels of b-catenin are
controlled by phosphorylation, either
directly on b-catenin or indirectly on
components of the destruction complex.
Suppression of the destruction complex
to stabilize b-catenin is well established
as the ‘‘canonical’’ pathway downstream
of WNT receptor activation. PGE2 signals
instead through GPCRs (EP1-4) to modu-
late numerous distinct kinase pathways,
including those regulated by SRC, PI3K/
AKT, and PKA. Cell-culture studies
suggest that PGE2-dependent pathwayscan also converge at the level of b-catenin
through several indirect mechanisms,
including association of the GPCR Gas
subunit with Axin, stimulation of the
PKA/cAMP pathway, or phosphorylation
of GSK3b (reviewed in Buchanan and
DuBois, 2006). Whether these observa-
tions in colon cancer cell lines (already
mutant for APC) are relevant to stem cell
biology had not been addressed. Goes-
sling et al. provide a comprehensive set
of data to demonstrate a conserved and
widely used stem cell and regeneration
pathway in which WNT and PGE2 collab-
orate to stabilize b-catenin (Goessling
et al., 2009).
The authors focused on the develop-
ment of long-term repopulating hemato-
poietic stem cells (HSCs), which arise in
vertebrates within the embryonic aorta-
gonad-mesonephros (AGM) region and
are marked by the expression of the
Runx1 transcription factor. In a lead-up
study, the Zon group used runx1 as
a marker to screen for small molecules
that enhance or suppress HSC generation
(North et al., 2007). They identified PGE2Cell Stemsynthesis as a common pathway associ-
ated with multiple chemical hits. Specifi-
cally, stabilized derivatives (dmPGE2)
enhance the number of runx1+ cells, while
COX2 inhibitors (indomethacin) block the
generation of this population. WNT
signaling through b-catenin is an estab-
lished regulator of adult bone marrow
hematopoiesis (Malhotra and Kincade,
2009) and the Zon and Moon groups
showed recently that it stimulates tissue
regeneration (Goessling et al., 2008).
Based on the colon carcinoma studies, it
made sense to consider whether the two
pathways intersect in vivo during HSC
development.
First, the investigators used a trans-
genic zebrafish line carrying a b-catenin-
responsive reporter (TOP:dGFP) and
found that canonical WNT signals in the
AGM and supporting endothelium are
enhanced or suppressed by addition of
dmPEG2, or indomethacin, respectively.
The number of Runx1+ cells in the AGM
was increased following induction of
Wnt8 expression, and this effect was
blocked by treatment with indomethacin.
Therefore, WNT signals enhance genera-
tion of HSC, and this outcome is depen-
dent on signals from PGE2 that promote
cell survival and cell proliferation. In
a series of tests for epistasis combining
specific pathway inhibitors with inducible
transgenic lines, the effect of PGE2 on
WNT activity was shown to converge at
a common point: the levels of phosphos-
tabilized b-catenin. The ability of PGE2
to modulate WNT was shown to be
dependent on cAMP/PKA signals, and
apparently not on PI3K signaling, which
may distinguish the stem cell mechanism
from at least some cancer cell models
(Figure 1). Goessling et al. next show
that the pathways cooperate not only
during embryogenesis, because synergy
is conserved during hematopoietic pro-
genitor cell recovery in irradiated adult
fish. The mechanism is also conserved
across species, since WNT and PGE2
combine to promote generation of murine
ESC-derived hematopoietic progenitors
in vitro and to enhance survival and repo-
pulating activity of bone marrow-derived
progenitors in transplanted hosts, even
whendonorHSCsareexposed topathway
modulators ex vivo. Finally, WNT signaling
was demonstrated to also be dependent
onPGE2activity in the context of zebrafish
liver and fin regeneration.Cell 4, April 3, 2009 ª2009 Elsevier Inc. 281
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solved. First, b-catenin is not required for
hematopoiesis. Whether this indepen-
dence is also true for tissue regeneration
is not known, although WNT signaling
activity may be a more pertinent criterion,
sinceeven theb-catenin/g-catenin double
knockout mice retain WNT-reporter
activity through an unknown compensa-
tory mechanism (Jeannet et al., 2008).
Second, sustained (chronic) stimulation
of either PGE2 or WNT signaling could
potentially have the opposite effect and
deplete stem cell activity (Kirstetter et al.,
2006; Scheller et al., 2006). Therefore, it
might be appropriate in a clinical setting
tomodulateb-catenin through thesepath-
ways, but there can be too much of
a ‘‘good thing.’’ It will be a tricky balancing
act to promote regeneration without
depletion of stem cell pools or promotion
of oncogenesis.
A second lesson provided by this study
is that elegant experimental approaches
in the zebrafish model system can be
combined in imaginative ways to reveal
mechanistic insight. The list of techniques
includes the use of reporter fish to quan-
tify in vivo signaling activities and stemOne Flew over the
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Articular cartilage is the target tissu
of Cell Stem Cell, Miosge and collea
degenerating OA tissue but that thi
In 1740, James Douglas, physician to the
Queen of England, was involved in
a monumental study on the nature of
bones and employed the noted anatomist
William Hunter to be his dissector. Doug-
las died 2 years later, but Hunter per-
sisted, and in 1743 the results of his
282 Cell Stem Cell 4, April 3, 2009 ª2009 Elcell populations, a repertoire of trans-
genics for manipulating signaling condi-
tionally, and the use of chemical biology
to identify new probes for blocking or
enhancing pathways to establish mecha-
nism. While each of the research tools
employed here was already available,
their combined use applied across
multiple organ systems in the embryo
and the adult demonstrates a very
impressive molecular toolbox for the
zebrafish model. The relative ease of
applying chemical probes and inducible
stimuli (in this case, heat, but many others
are conceivable), combined with lineage
reporters and tissue regeneration assays,
confirm the advantage of testing compli-
cated models in fish before moving on to
confirm they are conserved in mammalian
systems. The success of Goessling et al.
in this sense bodes well for future fishing
experiments and the discovery of novel
modulators to impact both cancer and
stem cell biology.
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observations on the structure of articular
cartilage and its diseases were published
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e disease with no cure. In this issue
t migratory progenitor cells occupy
cartilage.
surface when the pressure is taken off.’’
He also noted, ‘‘From Hippocrates to the
present age it is universally allowed that
ulcerated cartilage is a troublesome thing
and that, once destroyed, is not re-
paired.’’ Until recently, it was considered
that, in part, cartilage’s poor reparative
